Condition: Stargardt Disease · Stargardt Disease 1 · Cone Rod Dystrophy · Sponsor: Ascidian Therapeutics, Inc
This is an observational prescreening study. Individuals who are eligible for prescreening will undergo testing procedures that may be used to determine eligibility in ACDN-01 clinical trials.
This description comes directly from the study's public registry record.
Associate Director, Clinical Operations · 207-573-0412 · researchtrials@ascidian-tx.com
Always discuss trial participation with your own doctor first.
| University of San Francisco | San Francisco, California, United States | Recruiting |
| Vitreo Retinal Associates | Gainesville, Florida, United States | Recruiting |
| Wilmer Eye Institute at John Hopkins | Baltimore, Maryland, United States | Recruiting |
| Massachusetts Eye and Ear | Boston, Massachusetts, United States | Recruiting |
| University of Michigan Kellogg Eye Center | Ann Arbor, Michigan, United States | Recruiting |
| Cincinnati Eye Institute | Cincinnati, Ohio, United States | Recruiting |
| Retina Foundation of Texas | Dallas, Texas, United States | Recruiting |
| Retina Consultants of Texas | Houston, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06445322